- Three BGI Researchers Listed as Highly Cited Researchers
- China National GeneBank and Macquarie University Deepen Cooperation in Synthetic Biology
- Dr. Ren Wang, Senior Vice President of BGI Attended International Symposium on Agricultural Innovation for Family Farmers
- Successful Completion of China-Africa Public Health Training Program at CNGB
- Establishment of the first Macaca fascicularis gut microbiome gene catalog
- Establishing the first gene catalogue of Sprague-Dawley rat gut metagenome based on the BGISEQ-500 platform
- The international Sc2.0 Project is on track to build the world’s first synthetic yeast genome
- Avian-specific conserved genomic elements play important regulatory roles in the macroevolution of avian-specific features
- Leading Health Organizations in Canada and China Teaming up to Accelerate Precision Medicine
- World’s largest genomic organisation to collaborate with leading Queensland researchers
- Ranomics Partners with BGI to Classify Variants of Unknown Significance
- BGI and UW collaborate on precision medicine development
- Meet The Chinese Company That Wants To Be The Intel Of Personalized Medicine
- Chinese innovation : BGI’s code for success
- Prof. Huanming Yang to Receive Membership from Royal Danish Academy of Sciences and Letters
- UW, Chinese genomics group forge new partnership to advance biomedical research
Tel: +86-755-36307212Email: email@example.com
On October 31, 40 officers from the Bill & Melinda Gates Foundation (BMGF) Seattle headquarters and Beijing Representative Office met with BGI executives and visited China National Gene Bank (CNGB). Gates Foundation leaders included Yinuo Li, China Director from the Beijing office; Zhen Xing, Vice Director from Beijing; and Robert Rosen, Director at the Gates Foundation in Seattle. BGI President and Co-Founder Jian Wang, along with Xun Xu, Chief Executive Officer of CNGB and Director of BGI Research; Yanmei Zhu, Executive Vice President of BGI and Director of Strategic Planning; and Yiwu He, Vice Director of BGI International Development Center, welcomed the group and presented topics including BGI's Health and Poverty Alleviation programs in China, Epidemic Disease Control in Tibet, and the Belt and Road Initiative Genomics Alliance.
Jian Wang demonstrated BGI’s ongoing programs of control of infectious diseases in Tibet. BGI is helping the autonomous region and the CDC of China to achieve full coverage for the Tibetan population in screening for infection, making a significant contribution to controlling birth defects, as well as preventing major transmission of infectious diseases.
In addition, Yiwu He also illustrated BGI's Health and Poverty Alleviation programs in China, and the Belt and Road Initiative Genomic Alliance efforts in prevention and controlling infections, birth defects, and non-communicable diseases.
BGI has partnered with with the Gates Foundation since signing a Memorandum of Understanding in 2012 on Collaboration for Global Health and Agricultural Development. Over the past five years, BGI has collaborated with the Gates Foundation and 17 world leading universities and organizations on 22 research projects in maternal neonatal health and infectious disease.